448 related articles for article (PubMed ID: 18298086)
1. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA
Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086
[TBL] [Abstract][Full Text] [Related]
2. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
[TBL] [Abstract][Full Text] [Related]
3. Interactions of substrates at the surface of P450s can greatly enhance substrate potency.
Hegde A; Haines DC; Bondlela M; Chen B; Schaffer N; Tomchick DR; Machius M; Nguyen H; Chowdhary PK; Stewart L; Lopez C; Peterson JA
Biochemistry; 2007 Dec; 46(49):14010-7. PubMed ID: 18004886
[TBL] [Abstract][Full Text] [Related]
4. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
5. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
Murataliev MB; Feyereisen R
Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
[TBL] [Abstract][Full Text] [Related]
6. How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms.
Lüdemann SK; Lounnas V; Wade RC
J Mol Biol; 2000 Nov; 303(5):797-811. PubMed ID: 11061976
[TBL] [Abstract][Full Text] [Related]
7. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics simulations of P450 BM3--examination of substrate-induced conformational change.
Chang YT; Loew GH
J Biomol Struct Dyn; 1999 Jun; 16(6):1189-203. PubMed ID: 10447203
[TBL] [Abstract][Full Text] [Related]
9. P450BM-3: absolute configuration of the primary metabolites of palmitic acid.
Truan G; Komandla MR; Falck JR; Peterson JA
Arch Biochem Biophys; 1999 Jun; 366(2):192-8. PubMed ID: 10356283
[TBL] [Abstract][Full Text] [Related]
10. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
11. Heme-coordinating analogs of lauric acid as inhibitors of fatty acid omega-hydroxylation.
Lu P; Alterman MA; Chaurasia CS; Bambal RB; Hanzlik RP
Arch Biochem Biophys; 1997 Jan; 337(1):1-7. PubMed ID: 8990261
[TBL] [Abstract][Full Text] [Related]
12. The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid.
Li H; Poulos TL
Nat Struct Biol; 1997 Feb; 4(2):140-6. PubMed ID: 9033595
[TBL] [Abstract][Full Text] [Related]
13. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of the fatty acid hydroxylase activity of cytochrome P450BM-3 utilizing its functional domains.
Sevrioukova I; Truan G; Peterson JA
Arch Biochem Biophys; 1997 Apr; 340(2):231-8. PubMed ID: 9143326
[TBL] [Abstract][Full Text] [Related]
15. Roles of key active-site residues in flavocytochrome P450 BM3.
Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
[TBL] [Abstract][Full Text] [Related]
16. Conformational dynamics in cytochrome P450-substrate interactions.
Li H; Poulos TL
Biochimie; 1996; 78(8-9):695-9. PubMed ID: 9010597
[TBL] [Abstract][Full Text] [Related]
17. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties.
Fasan R; Chen MM; Crook NC; Arnold FH
Angew Chem Int Ed Engl; 2007; 46(44):8414-8. PubMed ID: 17886313
[No Abstract] [Full Text] [Related]
18. Are branched chain fatty acids the natural substrates for P450(BM3)?
Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
[TBL] [Abstract][Full Text] [Related]
19. Active site structure and substrate specificity of cytochrome P450 4A1: steric control of ligand approach perpendicular to heme plane.
Bambal RB; Hanzlik RP
Biochem Biophys Res Commun; 1996 Feb; 219(2):445-9. PubMed ID: 8605007
[TBL] [Abstract][Full Text] [Related]
20. Oxygen activation by cytochrome P450BM-3: effects of mutating an active site acidic residue.
Yeom H; Sligar SG
Arch Biochem Biophys; 1997 Jan; 337(2):209-16. PubMed ID: 9016815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]